Thor Medical ASA
(OSL:TRMED)
kr
2.655
-0.005 (-0.19%)
Market Cap: 744.71 Mil
Enterprise Value: 716.01 Mil
PE Ratio: 0
PB Ratio: 2.40
GF Score: 25/100 Nordic Nanovector ASA to Focus on Advancing PARADIGME and Actions to Extend Cash Runway Into 2021 Presentation Transcript
Apr 02, 2020 / 08:00AM GMT
Release Date Price:
kr13.64
(+7.41%)
Lars Nieba
Nordic Nanovector ASA - Interim CEO & CTO
Presentation
Apr 02, 2020 / 08:00AM GMT
=====================
Corporate Participants
=====================
* Jan Hendrik Egberts
Nordic Nanovector ASA - Independent Chairman of the Board
* Lars Nieba
Nordic Nanovector ASA - Interim CEO & CTO
* Malene Brondberg
Nordic Nanovector ASA - VP of IR & Corporate Communications
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot